Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Competitive Landscape Professional Research Report 2024

Research Summary

Mesenchymal stem cells (MSCs) and exosomes are key elements in the field of regenerative medicine and hold promise for diagnostics and therapies. MSCs are a type of adult stem cell that can be derived from various sources, such as bone marrow, adipose tissue, and umbilical cord, and possess the ability to differentiate into multiple cell types including bone, cartilage, and fat cells. These cells also exhibit immunomodulatory and anti-inflammatory properties, making them attractive for therapeutic applications. Exosomes, on the other hand, are small vesicles released by cells that contain various bioactive molecules, including proteins, nucleic acids, and microRNAs. They play a crucial role in intercellular communication and have shown potential as therapeutic vehicles due to their ability to transfer critical signaling molecules to target cells. In diagnostics, both MSCs and exosomes offer non-invasive approaches for assessing disease progression, predicting treatment response, and monitoring therapeutic outcomes. These technologies are being actively researched and developed for a wide range of conditions, including degenerative diseases, autoimmune disorders, tissue regeneration, and cancer. The field of MSC and exosome diagnostics and therapies holds great promise for advancing personalized medicine and improving patient outcomes.

According to DIResearch's in-depth investigation and research, the global Msenchymal Stem Cell and Exosome Diagnostics and Therapies market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Msenchymal Stem Cell and Exosome Diagnostics and Therapies include Tianjin Angsai Cell Genetic Engineering, Qingdao Aoke Biological Development, Beijing SH biotechnology, Shanghai Aisar Biotechnology, Beijing Beilai Biotechnology, Jiuzhitang Meike (Beijing) Cell Technology, Beijing Han's United Biotechnology, Bosheng Excellence Biotechnology (Beijing) , Cellular Biomedicine Group, Guangzhou Celera Stem Cell Technology, Stem Med, CryoCord, Cytopeutics Sdn Bhd, Stempeutics Research, Asian Institute of Gastroenterology etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Msenchymal Stem Cell and Exosome Diagnostics and Therapies. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Msenchymal Stem Cell and Exosome Diagnostics and Therapies market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Msenchymal Stem Cell and Exosome Diagnostics and Therapies market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Msenchymal Stem Cell and Exosome Diagnostics and Therapies industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Msenchymal Stem Cell and Exosome Diagnostics and Therapies Include:

Tianjin Angsai Cell Genetic Engineering

Qingdao Aoke Biological Development

Beijing SH biotechnology

Shanghai Aisar Biotechnology

Beijing Beilai Biotechnology

Jiuzhitang Meike (Beijing) Cell Technology

Beijing Han's United Biotechnology

Bosheng Excellence Biotechnology (Beijing)

Cellular Biomedicine Group

Guangzhou Celera Stem Cell Technology

Stem Med

CryoCord

Cytopeutics Sdn Bhd

Stempeutics Research

Asian Institute of Gastroenterology

Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Segment Include:

Autologous MSC Therapy

Allogeneic MSC Therapy

Adipose-Derived MSC Therapy

Bone Marrow-Derived MSC Therapy

Other

Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Application Include:

Diagnostics

Therapies

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry PESTEL Analysis

Chapter 3: Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry Porter's Five Forces Analysis

Chapter 4: Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Regional Market Size and Forecast Analysis

Chapter 5: Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Msenchymal Stem Cell and Exosome Diagnostics and Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Msenchymal Stem Cell and Exosome Diagnostics and Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Overview

1.1 Product Definition and Statistical Scope

1.2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product by Type

1.2.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Autologous MSC Therapy

1.2.3 Allogeneic MSC Therapy

1.2.4 Adipose-Derived MSC Therapy

1.2.5 Bone Marrow-Derived MSC Therapy

1.2.6 Other

1.3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product by Application

1.3.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Diagnostics

1.3.3 Therapies

1.4 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Revenue Analysis (2019-2030)

1.5 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Development Status and Trends

1.5.1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry Development Status Analysis

1.5.2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry Development Trends Analysis

2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Analysis by Regions

4.1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Overall Market: 2023 VS 2024 VS 2030

4.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue and Market Share by Region (2019-2024)

4.2.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Forecast by Region (2025-2030)

5 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type and Application

5.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type

5.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application

6 North America

6.1 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type

6.4 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application

6.5 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type

7.4 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application

7.5 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type

8.4 China Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type

9.4 APAC (excl. China) Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application

9.5 APAC (excl. China) Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type

10.4 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application

10.5 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type

11.4 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application

11.5 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Revenue by Key Manufacturers (2020-2024)

12.2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Competitive Landscape Analysis and Market Dynamic

12.2.1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Tianjin Angsai Cell Genetic Engineering

13.1.1 Tianjin Angsai Cell Genetic Engineering Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Tianjin Angsai Cell Genetic Engineering Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio

13.1.3 Tianjin Angsai Cell Genetic Engineering Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Qingdao Aoke Biological Development

13.2.1 Qingdao Aoke Biological Development Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Qingdao Aoke Biological Development Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio

13.2.3 Qingdao Aoke Biological Development Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Beijing SH biotechnology

13.3.1 Beijing SH biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Beijing SH biotechnology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio

13.3.3 Beijing SH biotechnology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Shanghai Aisar Biotechnology

13.4.1 Shanghai Aisar Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Shanghai Aisar Biotechnology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio

13.4.3 Shanghai Aisar Biotechnology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Beijing Beilai Biotechnology

13.5.1 Beijing Beilai Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Beijing Beilai Biotechnology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio

13.5.3 Beijing Beilai Biotechnology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Jiuzhitang Meike (Beijing) Cell Technology

13.6.1 Jiuzhitang Meike (Beijing) Cell Technology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Jiuzhitang Meike (Beijing) Cell Technology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio

13.6.3 Jiuzhitang Meike (Beijing) Cell Technology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Beijing Han's United Biotechnology

13.7.1 Beijing Han's United Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Beijing Han's United Biotechnology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio

13.7.3 Beijing Han's United Biotechnology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Bosheng Excellence Biotechnology (Beijing) 

13.8.1 Bosheng Excellence Biotechnology (Beijing)  Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Bosheng Excellence Biotechnology (Beijing)  Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio

13.8.3 Bosheng Excellence Biotechnology (Beijing)  Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Cellular Biomedicine Group

13.9.1 Cellular Biomedicine Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio

13.9.3 Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Guangzhou Celera Stem Cell Technology

13.10.1 Guangzhou Celera Stem Cell Technology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Guangzhou Celera Stem Cell Technology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio

13.10.3 Guangzhou Celera Stem Cell Technology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Stem Med

13.11.1 Stem Med Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Stem Med Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio

13.11.3 Stem Med Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 CryoCord

13.12.1 CryoCord Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 CryoCord Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio

13.12.3 CryoCord Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Cytopeutics Sdn Bhd

13.13.1 Cytopeutics Sdn Bhd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio

13.13.3 Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 Stempeutics Research

13.14.1 Stempeutics Research Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Stempeutics Research Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio

13.14.3 Stempeutics Research Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 Asian Institute of Gastroenterology

13.15.1 Asian Institute of Gastroenterology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio

13.15.3 Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry Chain Analysis

14.2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Typical Downstream Customers

14.4 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support